Planmed Oy gains Health Canada approval for new mammography systems

Planmed Oy, a Finland-based manufacturer of imaging solutions, announced this week that its Planmed Clarity 2D digital mammography system and Planmed Clarity 3D digital mammography tomosynthesis system have both received approval from Health Canada.

“This is a great next step for this unique product family,” Jan Moed, Planmed’s managing director, said in a prepared statement. “And we got the approval on the International Women’s Day, no less. I can’t think of a better way to celebrate Women’s Day.”

Moed also noted the importance of offering a 3D digital mammography solution.

“Planmed’s patented tomosynthesis method significantly improves image accuracy and allows even the smallest details to be captured with great precision,” she said. “The latest research indicates that tomosynthesis increases the cancer detection rate and reduces the recall rate.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.